|
1
|
Edwards KM, Davis JE, Browne KA, Sutton VR
and Trapani JA: Anti-viral strategies of cytotoxic T lymphocytes
are manifested through a variety of granule-bound pathways of
apoptosis induction. Immunol Cell Biol. 77:76–89. 1999. View Article : Google Scholar
|
|
2
|
Anderson DH, Sawaya MR, Cascio D, Ernst W,
Modlin R, Krensky A and Eisenberg D: Granulysin crystal structure
and a structure-derived lytic mechanism. J Mol Biol. 325:355–365.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kumar J, Okada S, Clayberger C and Krensky
AM: Granulysin: a novel antimicrobial. Expert Opin Investig Drugs.
10:321–329. 2001. View Article : Google Scholar
|
|
4
|
Feng Y, Huang N, Wu Q and Wang B: HMGN2: a
novel antimicrobial effector molecule of human mononuclear
leukocytes? J Leukoc Biol. 78:1136–1141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Postnikov YV, Herrera JE, Hock R, Scheer U
and Bustin M: Clusters of nucleosomes containing chromosomal
protein HMG-17 in chromatin1. J Mol Biol. 274:454–465. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Srikantha T, Landsman D and Bustin M:
Retropseudogenes for human chromosomal protein HMG-17. J Mol Biol.
197:405–413. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spieker N, Beitsma M, van Sluis P, Roobeek
I, den Dunnen JT, Speleman F, Caron H and Versteeg R: An integrated
5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region
implicated in neuroblastoma pathogenesis. Gene Chromosomes Cancer.
27:143–152. 2000. View Article : Google Scholar
|
|
8
|
Porkka K, Laakkonen P, Hoffman JA,
Bernasconi M and Ruoslahti E: A fragment of the HMGN2 protein homes
to the nuclei of tumor cells and tumor endothelial cells in vivo.
Proc Natl Acad Sci USA. 99:7444–7449. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bustin M: Regulation of DNA-dependent
activities by the functional motifs of the high-mobility-group
chromosomal proteins. Mol Cell Biol. 19:5237–5246. 1999.PubMed/NCBI
|
|
10
|
Czura CJ, Wang H and Tracey KJ: Dual roles
for HMGB1: DNA binding and cytokine. J Endotoxin Res. 7:315–321.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang H, Wang H and Tracey KJ: HMG-1
rediscovered as a cytokine. Shock. 15:247–253. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zetterström CK, Strand ML and Söder O: The
high mobility group box chromosomal protein 1 is expressed in the
human and rat testis where it may function as an antibacterial
factor. Hum Reprod. 21:2801–2809. 2006.PubMed/NCBI
|
|
13
|
Fernandes JM, Saint N, Kemp GD and Smith
VJ: Oncorhyncin III: a potent antimicrobial peptide derived from
the non-histone chromosomal protein H6 of rainbow trout,
Oncorhynchus mykiss. Biochem J. 373:621–628. 2003.
View Article : Google Scholar
|
|
14
|
Gerlitz G: HMGNs, DNA repair and cancer.
Biochim Biophys Acta. 1799:80–85. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Birger Y, Ito Y, West KL, Landsman D and
Bustin M: HMGN4, a newly discovered nucleosome-binding protein
encoded by an intronless gene. DNA Cell Biol. 20:257–264. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bustin M and Reeves R: High-mobility-group
chromosomal proteins: architectural components that facilitate
chromatin function. Prog Nucleic Acid Res Mol Biol. 54:35–100.
1996. View Article : Google Scholar
|
|
17
|
West KL, Ito Y, Birger Y, Postnikov Y,
Shirakawa H and Bustin M: HMGN3a and HMGN3b, two protein isoforms
with a tissue-specific expression pattern, expand the cellular
repertoire of nucleosome-binding proteins. J Biol Chem.
276:25959–25969. 2001. View Article : Google Scholar
|
|
18
|
Shirakawa H, Landsman D, Postnikov YV and
Bustin M: NBP-45, a novel nucleosomal binding protein with a
tissue-specific and developmentally regulated expression. J Biol
Chem. 275:6368–6374. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Birger Y, Catez F, Furusawa T, Lim JH,
Prymakowska-Bosak M, West KL, Postnikov YV, Haines DC and Bustin M:
Increased tumorigenicity and sensitivity to ionizing radiation upon
loss of chromosomal protein HMGN1. Cancer Res. 65:6711–6718. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rochman M, Malicet C and Bustin M:
HMGN5/NSBP1: a new member of the HMGN protein family that affects
chromatin structure and function. Biochim Biophys Acta. 1799:86–92.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li DQ, Hou YF, Wu J, Chen Y, Lu JS, Di GH,
Ou ZL, Shen ZZ, Ding J and Shao ZM: Gene expression profile
analysis of an isogenic tumour metastasis model reveals a
functional role for oncogene AF1Q in breast cancer metastasis. Eur
J Cancer. 42:3274–3286. 2006. View Article : Google Scholar
|
|
22
|
Tang WY, Newbold R, Mardilovich K,
Jefferson W, Cheng RY, Medvedovic M and Ho SM: Persistent
hypomethylation in the promoter of nucleosomal binding protein 1
(Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri
neonatally exposed to diethylstilbestrol or genistein.
Endocrinology. 149:5922–5931. 2008. View Article : Google Scholar
|
|
23
|
Popescu N, Landsman D and Bustin M:
Mapping the human gene coding for chromosomal protein HMG-17. Human
Genet. 85:376–378. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Okamura S, Ng CC, Koyama K, Takei Y,
Arakawa H, Monden M and Nakamura Y: Identification of seven genes
regulated by wild-type p53 in a colon cancer cell line carrying a
well-controlled wild-type p53 expression system. Oncol Res.
11:281–285. 1999.
|
|
25
|
Bustin M, Reisch J, Einck L and Klippel
JH: Autoantibodies to nucleosomal proteins: antibodies to HMG-17 in
autoimmune diseases. Science. 215:1245–1247. 1982. View Article : Google Scholar : PubMed/NCBI
|
